1
|
Haugwitz B. Music therapy in the early detection and indicated prevention in persons at risk of bipolar disorders: State of knowledge and potential. BRITISH JOURNAL OF MUSIC THERAPY 2021. [DOI: 10.1177/1359457521997386] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Bipolar disorders are among the most severe mental illnesses. The onset of the disorder is frequently preceded by phases with subsyndromal symptoms. In Germany, psychiatric early detection centres provide prevention services for help-seeking young people which focus on risk research. This article considers how music therapy contributes to the indicated prevention of bipolar disorders in preparation for a qualitative research study. The article presents a narrative literature review on research into early detection and prediction in bipolar disorders and approaches to prevention. The rationale for the use of music therapy in this context is discussed, with consideration of research questions leading to the next stage of the study.
Collapse
Affiliation(s)
- Beate Haugwitz
- University of Augsburg, Germany; University Hospital Carl Gustav Carus Dresden, Germany
| |
Collapse
|
2
|
Bechdolf A, Laier S, Kallenbach M, Biester A, Leopold K. [Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Con]. DER NERVENARZT 2015; 86:1424-1426. [PMID: 26542156 DOI: 10.1007/s00115-015-4428-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- A Bechdolf
- Frühinterventions- und Therapiezentrum - FRITZ am Urban, Vivantes Klinikum Am Urban, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Dieffenbachstr. 1, 10967, Berlin, Deutschland.
- Vivantes Klinikum im Friedrichshain, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Berlin, Deutschland.
- Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Köln, Köln, Deutschland.
- ORYGEN Youth Health, University of Melbourne, Melbourne, Australien.
| | - S Laier
- Frühinterventions- und Therapiezentrum - FRITZ am Urban, Vivantes Klinikum Am Urban, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Dieffenbachstr. 1, 10967, Berlin, Deutschland
- Vivantes Klinikum im Friedrichshain, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Berlin, Deutschland
| | - M Kallenbach
- Frühinterventions- und Therapiezentrum - FRITZ am Urban, Vivantes Klinikum Am Urban, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Dieffenbachstr. 1, 10967, Berlin, Deutschland
- Vivantes Klinikum im Friedrichshain, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Berlin, Deutschland
- Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Köln, Köln, Deutschland
| | - A Biester
- Frühinterventions- und Therapiezentrum - FRITZ am Urban, Vivantes Klinikum Am Urban, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Dieffenbachstr. 1, 10967, Berlin, Deutschland
- Vivantes Klinikum im Friedrichshain, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Berlin, Deutschland
| | - K Leopold
- Frühinterventions- und Therapiezentrum - FRITZ am Urban, Vivantes Klinikum Am Urban, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Dieffenbachstr. 1, 10967, Berlin, Deutschland
- Vivantes Klinikum im Friedrichshain, Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Akademisches Lehrkrankenhaus der Charité Medizin, Berlin, Deutschland
| |
Collapse
|
3
|
Abstract
After over 100 years of research without clarifying the aetiology of schizophrenia, a look at the current state of knowledge in epidemiology, genetics, precursors, psychopathology, and outcome seems worthwhile. The disease concept, created by Kraepelin and modified by Bleuler, has a varied history. Today, schizophrenia is considered a polygenic disorder with onset in early adulthood, characterized by irregular psychotic episodes and functional impairment, but incident cases occur at all ages with marked differences in symptoms and social outcome. Men’s and women’s lifetime risk is nearly the same. At young age, women fall ill a few years later and less severely than men, men more rarely and less severely later in life. The underlying protective effect of oestrogen is antagonized by genetic load. The illness course is heterogeneous and depressive mood the most frequent symptom. Depression and schizophrenia are functionally associated, and affective and nonaffective psychoses do not split neatly. Most social consequences occur at the prodromal stage. Neither schizophrenia as such nor its main symptom dimensions regularly show pronounced deterioration over time. Schizophrenia is neither a residual state of a neurodevelopmental disorder nor a progressing neurodegenerative process. It reflects multifactorial CNS instability, which leads to cognitive deficits and symptom exacerbations.
Collapse
|
4
|
Abstract
BACKGROUND The worldwide established early detection and prevention centers for psychosis follow the modern program of predictive, preventive and personalized medicine. OBJECTIVES If primary prevention is to succeed, the individual risk of the disease has to be estimated correctly and the psychosis onset has to be accurately predicted. Accordingly, this article presents the current possibilities for prediction. MATERIALS AND METHODS An overview on the recent prediction analyses in clinical high risk for psychosis research is provided. RESULTS The previously identified high-risk criteria achieve a considerable predictive power, which can be further enhanced by their combined use as well as other strategies of risk enrichment and risk stratification. CONCLUSIONS Clinical prediction already allows risk-adapted prevention measures and is currently being enhanced even further by additional biological brain diagnostics.
Collapse
Affiliation(s)
- J Klosterkötter
- Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum der Universität zu Köln, Kerpener Str. 62, 50924, Köln, Deutschland,
| |
Collapse
|